Inventor · disambiguated record
Yves Durocher
Also filed as: DUROCHER YVES
13 granted patents·12 pending applications·17 citations·filing 1999–2023
85Inventor score
Files withNAT RES COUNCIL CANADA16DUROCHER YVES5CA NAT RESEARCH COUNCIL1INSTITUTO NAC DE TECNOLOGIA AGROPECUARIA1MORENO MARIA1
Top patents by PatentIndex Score
25 records- 0185US8551774B2Expression vectors containing a truncated epstein barr nuclear antigen 1 lacking the Gly-Gly-Ala domain for enhanced transient gene expressionDUROCHER YVES·Filed 2006·Granted Oct 8, 2013·9 cites·3 claims
- 0280US10738115B2Humanized antibodies transmigrating the blood-brain barrier and uses thereofNAT RES COUNCIL CANADA·Filed 2017·Granted Aug 11, 2020·2 cites·14 claims
- 0378US11702466B2Fusion protein comprising a blood-brain barrier (BBB)-crossing single domain antibody Fc5, an immunoglobulin Fc fragment and a beta-amyloid binding polypeptide (ABP)NAT RES COUNCIL CANADA·Filed 2018·Granted Jul 18, 2023·1 cites·8 claims
- 0477US8637315B2Process, vectors and engineered cell lines for enhanced large-scale transfectionDUROCHER YVES·Filed 2009·Granted Jan 28, 2014·4 cites·8 claims
- 0573US2023279088A1Fusion protein comprising a blood-brain barrier (bbb)-crossing single domain antibody fc5, an immunoglobulin fc fragment and a beta-amyloid binding polypeptide (abp)NAT RES COUNCIL CANADA·Filed 2023·Application pending·0 cites
- 0664US10487153B2Carbonic anhydrase IX-specific antibodies and uses thereofNAT RES COUNCIL CANADA·Filed 2016·Granted Nov 26, 2019·1 cites·18 claims
- 0764US2025101105A1Antibodies with Engineered O-Glycosylation Sequons for Site-Specific ConjugationNAT RES COUNCIL CANADA·Filed 2023·Application pending·0 cites
- 0863US2025222129A1Lipid Based Nanoparticles for Targeted Gene Delivery to the BrainNAT RES COUNCIL CANADA·Filed 2023·Application pending·0 cites
- 0961US10858629B2Enhanced production of recombinant proteins by transient transfection of suspension-growing mammalian cellsNAT RES COUNCIL CANADA·Filed 2019·Granted Dec 8, 2020·0 cites·17 claims
- 1061US2010279937A1Method of Inhibiting Angiogenesis, Tumorigenesis and Cathepsin ActivityMORENO MARIA·Filed 2007·Application pending·0 cites
- 1158US2024301381A1Ace2-receptor ectodomain fusion molecules and uses thereofNAT RES COUNCIL CANADA·Filed 2022·Application pending·0 cites
- 1257US2023257424A1Blood-brain barrier transmigrating compounds and uses thereofNAT RES COUNCIL CANADA·Filed 2018·Application pending·0 cites
- 1356US9353382B2Process, vectors and engineered cell lines for enhanced large-scale transfectionNAT RES COUNCIL CANADA·Filed 2013·Granted May 31, 2016·0 cites·14 claims
- 1456US2024425875A1Expression system for constitutive or cumate-inducible expression in cho cellsNAT RES COUNCIL CANADA·Filed 2022·Application pending·0 cites
- 1553US2023174591A1Use of Human Resistin as a Trimerization Partner for Expression of Trimeric ProteinsNAT RES COUNCIL CANADA·Filed 2021·Application pending·0 cites
- 1653US2024010686A1Dna construct for stably producing empty capsids of the foot-and-mouth disease virus in mammalian cells; processes, uses, and compositions thereofINSTITUTO NAC DE TECNOLOGIA AGROPECUARIA·Filed 2021·Application pending·0 cites
- 1751US11591408B2Antibody glycoconjugates and methods of production and useNAT RES COUNCIL CANADA·Filed 2018·Granted Feb 28, 2023·0 cites·19 claims
- 1850US12240916B2Intrabodies for reducing FUT8 activityNAT RES COUNCIL CANADA·Filed 2019·Granted Mar 4, 2025·0 cites·16 claims
- 1950US9085627B2Expression system with SAR element from IFNα2DUROCHER YVES·Filed 2012·Granted Jul 21, 2015·0 cites·14 claims
- 2048US10421950B2Enhanced production of recombinant proteins by transient transfection of suspension-growing mammalian cellsDUROCHER YVES·Filed 2002·Granted Sep 24, 2019·0 cites·11 claims
- 2147US2022363723A1Viral Origin of Replication to Increase Protein Productivity from Mammalian CellsNAT RES COUNCIL CANADA·Filed 2020·Application pending·0 cites
- 2244US2010261275A1Production of Recombinant Interferon ProteinsDUROCHER YVES·Filed 2008·Application pending·0 cites
- 2341US11945858B2Antibodies and antibody fragments against HNAV1.7 channel and their use in pain and cancer indicationsNAT RES COUNCIL CANADA·Filed 2019·Granted Apr 2, 2024·0 cites·18 claims
- 2439US2009048158A1Insulin-Like Growth Factor Binding Protein-4 Compounds and Methods for Inhibiting Angiogenesis and Tumor Growth in Mammalian CellsMORENO MARIA J·Filed 2006·Application pending·0 cites
- 2528US6596508B2CRE-inducible expression systemCA NAT RESEARCH COUNCIL·Filed 1999·Granted Jul 22, 2003·0 cites·7 claims
Join the waitlist — get patent alerts
Get an alert when Yves Durocher files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →